These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 23445227)

  • 1. Triglyceride levels, pancreatitis and choice of lipid-modifying therapy.
    Preiss D
    Expert Rev Gastroenterol Hepatol; 2013 Mar; 7(3):193-5. PubMed ID: 23445227
    [No Abstract]   [Full Text] [Related]  

  • 2. Drugs for hypertriglyceridemia.
    Med Lett Drugs Ther; 2013 Mar; 55(1411):17-9. PubMed ID: 23467119
    [No Abstract]   [Full Text] [Related]  

  • 3. [Update: clinical lipidology].
    Parhofer KG
    MMW Fortschr Med; 2013 Jul; 155(13):49-52; quiz 53-4. PubMed ID: 23964509
    [No Abstract]   [Full Text] [Related]  

  • 4. Lipid-modifying therapies and risk of pancreatitis: a meta-analysis.
    Preiss D; Tikkanen MJ; Welsh P; Ford I; Lovato LC; Elam MB; LaRosa JC; DeMicco DA; Colhoun HM; Goldenberg I; Murphy MJ; MacDonald TM; Pedersen TR; Keech AC; Ridker PM; Kjekshus J; Sattar N; McMurray JJ
    JAMA; 2012 Aug; 308(8):804-11. PubMed ID: 22910758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determining triglyceride reductions needed for clinical impact in severe hypertriglyceridemia.
    Christian JB; Arondekar B; Buysman EK; Jacobson TA; Snipes RG; Horwitz RI
    Am J Med; 2014 Jan; 127(1):36-44.e1. PubMed ID: 24384100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Multimodal therapy of dyslipidemia].
    Stahn A; Hanefeld M
    Clin Res Cardiol Suppl; 2011 May; 6():10-6. PubMed ID: 22528173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of fibrates in clinical practice: Queensland Lipid Group consensus recommendations.
    Hamilton-Craig I; Kostner KM; Woodhouse S; Colquhoun D
    Int J Evid Based Healthc; 2012 Sep; 10(3):181-90. PubMed ID: 22925614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Introduction to drug therapy].
    Ishii H; Yoshida M
    Nihon Rinsho; 2013 Sep; 71(9):1636-40. PubMed ID: 24205727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pleiotrophic effect of anti-hyperlipemic agents].
    Morishita R
    Nihon Naika Gakkai Zasshi; 2001 Oct; 90(10):2017-22. PubMed ID: 11769493
    [No Abstract]   [Full Text] [Related]  

  • 10. [Fibrates: their prescription must be restricted].
    Béliard-Lasserre S
    Rev Prat; 2015 Dec; 65(10):1243-4. PubMed ID: 26979011
    [No Abstract]   [Full Text] [Related]  

  • 11. Treating hypertriglyceridemia.
    Holub BJ
    CMAJ; 2007 Sep; 177(6):604; author reply 604-5. PubMed ID: 17846446
    [No Abstract]   [Full Text] [Related]  

  • 12. Hypertriglyceridemia Therapy: Past, Present and Future Perspectives.
    Canfora I; Pierno S
    Int J Mol Sci; 2024 Sep; 25(17):. PubMed ID: 39273674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. All at sea: new lipid-lowering drug trials continue to disappoint.
    Wierzbicki AS
    Int J Clin Pract; 2013 Jul; 67(7):595-8. PubMed ID: 23758438
    [No Abstract]   [Full Text] [Related]  

  • 14. Endocrine society releases guidelines on diagnosis and management of hypertriglyceridemia.
    Endocrine Society
    Am Fam Physician; 2013 Jul; 88(2):142-4. PubMed ID: 23939649
    [No Abstract]   [Full Text] [Related]  

  • 15. Incidence of pancreatitis, secondary causes, and treatment of patients referred to a specialty lipid clinic with severe hypertriglyceridemia: a retrospective cohort study.
    Sandhu S; Al-Sarraf A; Taraboanta C; Frohlich J; Francis GA
    Lipids Health Dis; 2011 Sep; 10():157. PubMed ID: 21906399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical nutrition therapy is the essential cornerstone for effective treatment of "refractory" severe hypertriglyceridemia regardless of pharmaceutical treatment: Evidence from a Lipid Management Program.
    Rhodes KS; Weintraub M; Marchlewicz EH; Rubenfire M; Brook RD
    J Clin Lipidol; 2015; 9(4):559-67. PubMed ID: 26228674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of hypertriglyceridemia for prevention of atherosclerotic cardiovascular disease.
    Brinton EA
    Cardiol Clin; 2015 May; 33(2):309-23. PubMed ID: 25939302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of fibrate-statin combination therapy on cardiovascular events: a retrospective cohort analysis.
    Wierzbicki AS; Morrell J; Hemsley D; McMahon Z; Crook MA; Wray R
    Curr Med Res Opin; 2010 Sep; 26(9):2141-6. PubMed ID: 20662558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertriglyceridemia: A review of the evidence.
    Elkins C; Friedrich D
    Nurse Pract; 2018 Oct; 43(10):22-29. PubMed ID: 30153192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triglycerides and endothelial function: molecular biology to clinical perspective.
    Kajikawa M; Higashi Y
    Curr Opin Lipidol; 2019 Oct; 30(5):364-369. PubMed ID: 31348023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.